Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa.
Subramaniam
S
S
Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada T2N 2T9.
Demchuk
A M
AM
Watson
T
T
Barber
P A
PA
Hill
M D
MD
D000368:Aged; D005167:Factor VII / Q000009:adverse effects* / Q000627:therapeutic use; D015942:Factor VIIa; D005260:Female; D006801:Humans; D006849:Hydrocephalus / Q000139:chemically induced*; D020300:Intracranial Hemorrhages / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa